Changeflow GovPing Healthcare FDA Submission for Harmony Foods Magnesium Citr...
Routine Notice Added Final

FDA Submission for Harmony Foods Magnesium Citrate Gummies

Favicon for www.regulations.gov Regs.gov: Food and Drug Administration
Detected March 18th, 2026
Email

Summary

The FDA has received a submission from Harmony Foods LLC regarding their Meijer Magnesium Citrate Gummies. This notice pertains to a product submission and does not contain new regulatory requirements or guidance.

View original document View source feed page

What changed

This document is a notice from the FDA regarding a submission for Harmony Foods LLC's Meijer Magnesium Citrate Gummies. The submission, identified by docket number FDA-2025-S-0024-1945, relates to a dietary supplement product. No new regulations, guidance, or enforcement actions are detailed within this notice.

Regulated entities should note that this is an informational filing. No immediate compliance actions are required based on this specific document. It serves as a record of a product submission received by the FDA.

Source document (simplified)

Content

There are no documents available to view or download

Attachments 1

2025-002070 - Harmony Foods LLC. - Meijer Magnesium Citrate Gummies 60ct - Supports Nerve, Bone and Muscle Health

More Information
- Author(s) HFP
Download

Related changes

Favicon for www.regulations.gov FDA Complaint Posted
Routine Mar 26, 2026 • Regs.gov: Food and Drug Administration • Healthcare
Favicon for www.regulations.gov FDA Complaint Filed
Routine Mar 26, 2026 • Regs.gov: Food and Drug Administration • Healthcare
Favicon for www.regulations.gov FDA Complaint Posted
Routine Mar 26, 2026 • Regs.gov: Food and Drug Administration • Healthcare
Favicon for www.fda.gov Falcon Trading Company Recalls Organic Black Beans for Pesticide Residue
Urgent Mar 26, 2026 • FDA Recalls & Safety Alerts • Pharma & Drug Safety
Favicon for www.fda.gov Gear Isle Recalls Chocolate for Undeclared Sildenafil and Tadalafil
Urgent Mar 26, 2026 • FDA Recalls & Safety Alerts • Pharma & Drug Safety
Favicon for changeflow.com Process for Isolating Osteopontin and Glycomacropeptide from Whey
Routine Mar 26, 2026 • ChangeBridge: Patent Apps - Peptides (C07K) • Pharma & Drug Safety

Source

Favicon for www.regulations.gov
Regs.gov: Food and Drug Administration regulations.gov/search?agencyIds=FDA&sortBy=postedDate&sortDirection=desc
Healthcare
Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
FDA
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Food manufacturers
Geographic scope
National (US) National (US)

Taxonomy

Primary area
Food Safety
Operational domain
Compliance
Topics
Dietary Supplements Product Submissions

Browse Categories

Agriculture & Food Safety 62 AI Regulation 3 Banking & Finance 241 Consumer Protection 41 Courts & Legal 324 Data Privacy & Cybersecurity 65 Defense & National Security 49 Education 20 Energy 105 Environment 84 Government & Legislation 265 Healthcare 134 Housing 16 Immigration 9 Insurance 56 Labor & Employment 114 Legal & Courts 1 Pharma & Drug Safety 101 Securities & Markets 81 Tax 64 Tax & Revenue 1 Telecom & Technology 48 Trade & Sanctions 124 Transportation 56

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.